KLBF:IDX
Kalbe Farma Tbk PT
780,00 IDR
0,00%
(0,00) 1D
14 ოქტ, 16:11:07 GMT+7 · IDR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLBF...
Open
780 IDR
High
795 IDR
Low
765 IDR
Mkt. cap
36,51 ტრლ.
Avg. vol.
65,90 მლნ.
Volume
44,50 მლნ.
Dividend
2,56%
Quarterly dividend
5 IDR
Ex-dividend date
4 ივნ. 2026
P/E ratio
9,80
52-wk high
1 345 IDR
52-wk low
630 IDR
EPS
80 IDR
Shares outstanding
46,81 მლრდ.
No. of employees
13 ათ.
Open
780 IDR
High
795 IDR
Low
765 IDR
Mkt. cap
36,51 ტრლ.
Avg. vol.
65,90 მლნ.
Volume
44,50 მლნ.
Dividend
2,56%
Quarterly dividend
5 IDR
Ex-dividend date
4 ივნ. 2026
P/E ratio
9,80
52-wk high
1 345 IDR
52-wk low
630 IDR
EPS
80 IDR
Shares outstanding
46,81 მლრდ.
No. of employees
13 ათ.
News stories
From web sources and news partners
Quiver Quantitative
·
35 წუთის წინ
Hecate Energy Appoints Michael J. Garofola as General Counsel Ahead of Planned Nasdaq Listing
NAI500
·
13 წუთის წინ
Agility Robotics On Track for November Nasdaq Listing as First U.S. Pure-Play Humanoid Robot Maker
Corsicana Daily Sun
·
43 წუთის წინ
Brightline Interactive Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance
·
21 წუთის წინ
S&P 500, Dow futures inch up before inflation data; bank results in focus
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About Kalbe Farma Tbk PT
CEO-
Employees12,8 ათ.
Founded10 სექ. 1966
Headquarters-
SectorPharmaceutical industry
Websitekalbe.co.id